Viewing Study NCT04881032


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-01-10 @ 3:59 AM
Study NCT ID: NCT04881032
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-13
First Post: 2021-04-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
Sponsor: Centre Jean Perrin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module